Skip to main content

Table 2 Genotypes distributions of TNFRSF5 SNPs among control, spontaneous clearance and persistent infection groups

From: CD40 polymorphisms were associated with HCV infection susceptibility among Chinese population

SNPs (genotype)

Group A

Group B

Group C

Group (B + C)/Group A

Group C/Group B

n(%)

n(%)

n(%)

OR(95%CI)a

P a

OR(95%CI)b

P b

rs1535045

 CC

688 (46.5)

214 (43.9)

328 (43.6)

1.00

–

1.00

–

 CT

648 (43.8)

211 (43.3)

322 (42.8)

1.043 (0.884-1.231)

0.618

0.979 (0.763-1.256)

0.867

 TT

142 (9.7)

62 (12.8)

103 (13.6)

1.397 (1.078-1.809)

0.011

1.095 (0.760-1.576)

0.626

Dominant model

   

1.109 (0.948-1.297)

0.197

1.005 (0.796-1.271)

0.964

Additive model

   

1.135 (1.011-1.275)

0.032

1.027 (0.869-1.215)

0.752

Recessive model

   

1.368 (1.070-1.749)

0.012

1.106 (0.785-1.559)

0.564

rs1883832

 CC

567 (39.4)

178 (37.3)

275 (37.7)

1.00

–

1.00

–

 CT

693 (48.2)

217 (45.5)

333 (45.6)

1.019 (0.858-1.210)

0.833

1.008 (0.778-1.306)

0.951

 TT

178 (12.4)

82 (17.2)

122 (16.7)

1.351 (1.060-1.722)

0.015

0.980 (0.695-1.383)

0.909

Dominant model

   

1.090 (0.926-1.282)

0.300

1.001 (0.785-1.275)

0.997

Additive model

   

1.127 (1.004-1.263)

0.042

0.993 (0.841-1.173)

0.937

Recessive model

   

1.337 (1.069-1.673)

0.011

0.976 (0.713-1.335)

0.878

rs4810485

 GG

604 (40.6)

190 (39.7)

306 (41.0)

1.00

–

1.00

–

 GT

693 (46.6)

211 (44.1)

328 (43.9)

0.970 (0.819-1.148)

0.721

0.981 (0.761-1.266)

0.885

 TT

191 (12.8)

78 (16.2)

113 (15.1)

1.201 (0.944-1.527)

0.136

0.927 (0.655-1.312)

0.667

Dominant model

   

1.021 (0.871-1.196)

0.802

0.967 (0.762-1.227)

0.780

Additive model

   

1.063 (0.949-1.190)

0.290

0.967 (0.819-1.141)

0.688

Recessive model

   

1.220 (0.976-1.526)

0.081

0.936 (0.679-1.290)

0.685

  1. Abbreviations: CI confidence interval, HCV hepatitis C virus, OR odds ratio, SNP single nucleotide polymorphism
  2. Group A: controls; Group B: spontaneous clearance subjects; Group C: persistent infection patients. Group (B + C): Infected individuals
  3. aThe P value, OR and 95% CIs of Group (B + C) versus Group A were calculated on the basis of the logistic regression model, adjusted by gender, age and routes of infection
  4. bThe P value, OR and 95% CIs of Group C versus Group B were calculated on the basis of the logistic regression model, adjusted by gender, age and routes of infection
  5. Bonferroni correction was applied and the P value was adjusted to 0.0167 (0.05/3)
  6. Bold type indicates statistically significant results